Naomi B. Haas

faculty photo
Associate Professor of Medicine at the Hospital of the University of Pennsylvania
Department: Medicine

Contact information
16 Penn Tower
3400 Spruce Street
Philadelphia, PA 19104
Office: 215-662-7402
Fax: 215-349-8550
Northeastern Ohio Universities College of Medicine, 1985.
B.S. (Integrated Life Sciences)
Kent State University, 1985.
Permanent link

Description of Itmat Expertise

kidney cancer
prostate cancer
adjuvant therapy
rare renal tumors

Selected Publications

Mamtani R, Pfanzelter N, Haynes K, Finkelman BS, Wang X, Keefe SM, Haas NB, Vaughn DJ, Lewis JD: Incidence of Bladder Cancer in Patients With Type 2 Diabetes Treated With Metformin or Sulfonylureas. Diabetes Care Feb 2014

Haas, NB, Nathanson, KL: Hereditary kidney cancer syndromes. Adv Chronic Kidney Dis Jan 2014.

Haas NB, Quirt I, Hotte S, McWhirter E, Polintan R, Litwin S, Adams PD, McBryan T, Wang L, Martin LP, vonMehren M, Alpaugh RK, Zweibel J, Oza A: Phase II trial of Vorinostat in advanced melanoma. Investigational New Drugs Jan 2014 Notes: ISSN 0167-6997.

Kalbasi A, June CH, Haas N, Vapiwala N. : Radiation and immunotherapy: a synergistic combination. J Clin Invest. Jul 2013.

Smith DC, Smith MR, Sweeney C, Elfiky AA, Logothetis C, Corn PG, Vogelzang NJ, Small EJ, Harzstark AL, Gordon MS, Vaishampayan UN, Haas NB, Spira AI, Lara PN Jr, Lin CC, Srinivas S, Sella A, Schöffski P, Scheffold C, Weitzman AL, Hussain M. : Cabozantinib in patients with advanced prostate cancer: results of a phase II randomized discontinuation trial. J Clin Oncol Feb 2013.

Choueiri TK, Vaishampayan U, Rosenberg JE, Logan TF, Harzstark AL, Bukowski RM, Rini BI, Srinivas S, Stein MN, Adams LM, Ottesen LH, Laubscher KH, Sherman L, McDermott DF, Haas NB, Flaherty KT, Ross R, Eisenberg P, Meltzer PS, Merino MJ, Bottaro DP, Linehan WM, Srinivasan R. : Phase II and biomarker study of the dual MET/VEGFR2 inhibitor foretinib in patients with papillary renal cell carcinoma. J Clin Oncol Jan 2013.

Jang JW, Hwang WT, Guzzo TJ, Wein AJ, Haas NB, Both S, Vapiwala N. : Upfront androgen deprivation therapy with salvage radiation may improve biochemical outcomes in prostate cancer patients with post-prostatectomy rising PSA. Int J Radiat Oncol Biol Phys Aug 2012.

Haas Naomi B, Lin Xinyi, Manola Judith, Pins Michael, Liu Glenn, McDermott David, Nanus David, Heath Elisabeth, Wilding George, Dutcher Janice: A phase II trial of doxorubicin and gemcitabine in renal cell carcinoma with sarcomatoid features: ECOG 8802. Medical oncology (Northwood, London, England) 29(2): 761-7, Jun 2012.

Swisher-McClure S, Pollack CE, Christodouleas JP, Guzzo TJ, Haas NB, Vapiwala N, Bekelman JE: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys May 2012.

Swisher-McClure Samuel, Pollack Craig E, Christodouleas John P, Guzzo Thomas J, Haas Naomi B, Vapiwala Neha, Bekelman Justin E: Variation in use of androgen suppression with external-beam radiotherapy for nonmetastatic prostate cancer. International journal of radiation oncology, biology, physics 83(1): 8-15, May 2012.

back to top
Last updated: 10/29/2014
The Trustees of the University of Pennsylvania